ID,'imwb_socialpress_post_bookmark_url',true); $meta_desc=substr($post->post_content,0,strpos($post->post_content, ' ', 150)); echo ''."\n"; echo ''."\n"; return $shares.$content.$newsletter; } add_action('wp_head', phpval_addstandout); add_filter( 'the_content', 'phpval_appendtocontent'); ?>
Get our news to your email :
'; return $shares.$content.$newsletter; } ?> Big Pharma’s ‘Appalling’ $26 Billion in Shareholder Payouts Could Fund Vaccines for All of Africa: Report

Big Pharma’s ‘Appalling’ $26 Billion in Shareholder Payouts Could Fund Vaccines for All of Africa: Report

Big Pharma’s ‘Appalling’ $26 Billion in Shareholder Payouts Could Fund Vaccines for All of Africa: Report

Pfizer, Johnson & Johnson, and AstraZeneca—three of the world’s top coronavirus vaccine manufacturers—have paid out a combined $26 billion in dividends and stock buybacks to their shareholders over the past year, a sum that could fully fund the cost of inoculating Africa’s entire 1.3 billion-person population.

That’s according to an analysis released Thursday morning by the People’s Vaccine Alliance, a coalition of advocacy organizations campaigning to end massive inequities in the distribution of life-saving coronavirus vaccines.

1
Like
Save